11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.

C-H Pui(St. Jude Children's Research Hospital), Wayne L. Furman(St. Jude Children's Research Hospital), Raul C. Ribeiro(St. Jude Children's Research Hospital), David R. Head(University of Southern California), F G Behm(St. Jude Children's Research Hospital), SA Shurtleff, John T. Sandlund(St. Jude Children's Research Hospital), Hazem H. Mahmoud(St. Jude Children's Research Hospital), M L Hancock(St. Jude Children's Research Hospital), J R Downing(St. Jude Children's Research Hospital)
Journal of Clinical Oncology
May 1, 1994
10.1200/jco.1994.12.5.909
Cited by 208

Related Papers

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
|Blood|1997|869
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|Journal of Clinical Oncology|1990|786
The genomic landscape of hypodiploid acute lymphoblastic leukemia
|Nature Genetics|2013|737